Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions

Journal of the American Society of Nephrology

Volumn 10, Issue 4, 1999, Pages 822-832

  Suzuki, Daisuke ^a   Miyata, Toshio ^a   Saotome, Noboru ^a   Horie, Katsunori ^a   Inagi, Reiko ^a   Yasuda, Yoshinari ^a   Uchida, Koji ^b   Izuhara, Yuko ^a   Yagame, Mitsunori ^a   Sakai, Hideto ^a   Kurokawa, Kiyoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBONYL DERIVATIVE; CARBOXYMETHYLLYSINE; CREATININE; GLUCOSE; MALONDIALDEHYDE LYSINE; PENTOSIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION;

EID: 0033055417     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. The Diabetes Control and Complications (DCCT) Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 47: 1703-1720, 1995
2. Bangstad HJ, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF: Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483-490, 1994
3. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
4. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469, 1993
5. Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, Kawashima S, van Ypersele de Strihou C, Kurokawa K: Plasma levels of pentosidine in diabetic patients: An advanced glycation end product. J Am Soc Nephrol 9: 1681-1688, 1998
6. Sell DR, Lapolla A, Odetti P, Forgarty J, Monnier VM: Pentosidine formation in skin correlates with severity of complication in individuals with long standing IDDM. Diabetes 41: 1286-1292, 1992
7. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thrope SR, Baynes JW, Lyons TJ: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91: 2470-2478, 1993
8. Beisswenger PJ, Moore LL, Brink-Johnsen T: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92: 212-217, 1993
9. Suzuki D, Yagame M, Naka R, Jinde K, Endoh M, Nomoto Y, Sakai H, Araki N, Horiuchi S: Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin dependent diabetes mellitus using monoclonal anti-body to advanced glycation end products. Nephrology 1: 199-205, 1995
10. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersele de Strihou C, Monnier VM, Witztum JL, Kurokawa K: Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 100: 2995-3004, 1997
11. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240: 1546-1548, 1998
12. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 93: 521-528, 1994
13. 2-microglobulin modified with advanced glycation end products. Kidney Int 49: 538-550, 1996
14. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Ellison K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992
15. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. J Clin Invest 98: 1088-1094, 1996
16. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 174: 931-939, 1991
17. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89: 2873-2877, 1992
18. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, Migheli A, Stern D: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712, 1993
19. Ahmed MU, Thorpe SR, Baynes JW: Identification of N∈-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889-4894, 1986
20. Sell DR, Monnier VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264: 21597-21602, 1989
21. Njoroge FG, Sayre LM, Monnier VM: Detection of glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res 167: 211-220, 1987
22. Baynes JW: Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991
23. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW: Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34: 3702-3709, 1995
24. Glomb MA, Monnier VM: Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026, 1995
25. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55: 389-399, 1999
26. Ahmed MU, Frye EB, Thorpe SR, Baynes JW: N∈-(carboxy-methyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324: 565-570, 1997
27. ∈ (carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29: 10964-10970, 1990
28. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Maeda K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51: 1170-1181, 1997
29. ∈-(carboxymethyl) lysine, is a product of lipid peroxidation and glycoxidation reactions. J Biol Chem 271: 9982-9986, 1996
30. Esterbauer H, Schuer RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehyde. Free Radic Biol Med 11: 81-128, 1991
31. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Suzuki D, Miyata T, Noguchi N, Niki E, Osawa T: Protein-bound acrolein: Potential markers for oxidative stress. Proc Natl Acad Sci USA 95: 4882-4887, 1998
32. Anderson MM, Hazen SL, Hsu FF, Heinecke JW: Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanol, and acrolein. J Clin Invest 99: 424-432, 1997
33. Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, Nomoto Y, Sakai H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52: 111-119, 1997
34. Sakai H, Abe K, Kobayashi Y, Koyama A, Shigematsu H, Harada T, Yoshikawa N, Arakawa M, Itoh H, Osawa G, Sakai O, Dohi K, Yamanaka N, Nagasawa T, Kurokawa K: Clinical guidelines of IgA nephropathy. Jpn J Nephrol 37: 417-421, 1995
35. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93: 2353-2358, 1996
36. Uchida K, Szweda LI, Chae HZ, Stadtman ER: Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA 90: 8742-8746, 1993
37. Rosenfeld ME, Palinski W, Herttula SY, Butler S, Witztum JL: Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336-349, 1990
38. Palinski W, Herttula SY, Rosenfeld ME, Butler SW, Socher SA, Parthasathy S, Curtiss LK, Witztum JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325-335, 1990
39. Horiuchi S, Araki N, Morino Y: Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 266: 7329-7332, 1991
40. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92: 1243-1252, 1993
41. ∈-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35: 8075-8083, 1996
42. Gugliucci A, Bendayan M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39: 149-160, 1996
43. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele de Strihou C, Kurokawa K: Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney Int 53: 416-422, 1998
44. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206, 1996
45. Miyata T, Inagi R, Asahi K, Yamada Y, Horie K, Sakai H, Uchida K, Kurokawa K: Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett 437: 24-28, 1998
46. Rhodes J: Covalent chemical events in immune induction: Fundamental and therapeutic aspects. Immunol Today 9: 436-441, 1996
47. Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogl S, Poli G: The lipoxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J 11: 851-857, 1997
48. c-Src. J Cell Biochem 72: 1-7, 1999
49. Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, Kawata K, Koike T: Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 46: 895-899, 1997
50. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632, 1986
51. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 9: 2349-2356, 1998
52. Miyata T, Ishikawa S, Asahi K, Inagi R, Suzuki D, Horie K, Tatsumi K, Kurokawa K: 2-Isopropylidenehydrazono-4-oxothiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimai thickening after balloon injury of rat carotid artery: Role of glycoxidation and lipoxidation reactions in vascular tissue damage. FEBS Lett 1999, in press
53. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40: 1328-1334, 1991